OBESITY, ABDOMINAL
Clinical trials for OBESITY, ABDOMINAL explained in plain language.
Never miss a new study
Get alerted when new OBESITY, ABDOMINAL trials appear
Sign up with your email to follow new studies for OBESITY, ABDOMINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Soda ban at work shrinks waistlines? new study investigates
Disease control CompletedThis study tested a two-part approach to help employees lose belly fat and improve insulin sensitivity: a workplace ban on sugary drinks and a single counseling session. Over 600 full-time employees who drank at least three sugary beverages a week took part. Researchers measured …
Matched conditions: OBESITY, ABDOMINAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Fatty liver breakthrough? drug that boosts growth hormone shows promise
Disease control CompletedThis study tested a drug called tesamorelin in 51 obese adults with nonalcoholic fatty liver disease (NAFLD). The drug is designed to increase growth hormone levels, which may help reduce liver fat and inflammation. Researchers measured changes in liver fat using special scans an…
Matched conditions: OBESITY, ABDOMINAL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC